Joseph Lim, M.D.

Assistant Professor of Medicine
Director, Yale Viral Hepatitis Program
Section of Digestive Diseases
more on this physician

Clinical Interests

Liver Disease

Research Interests

Acute and chronic liver diseases, with emphasis on: 1) Viral hepatitis B and C, and 2) Fatty liver disorders, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).

Dr. Lim is a graduate of Northwestern University Medical School (Chicago, IL), and completed his internship and residency in Internal Medicine at Yale- New Haven Hospital (New Haven , CT). He then completed a clinical and research fellowship in Gastroenterology and Hepatology at Stanford University Medical Center (Palo Alto , CA) as a recipient of an NIH institutional training grant. He has served in various leadership roles, including national chair of the resident/fellow section of the American College of Physicians (ACP), and section editor of Journal of the American Medical Association (JAMA), for which he has served on the Editorial Board, and developed a new, peer-reviewed section focused on graduate medical education. He is a peer reviewer for multiple journals, including Annals of Internal Medicine, Journal of General Internal Medicine, American Journal of Gastroenterology, Gastrointestinal Endoscopy, and Hepatology. He is currently involved in multiple aspects of the clinical practice within the Section of Digestive Diseases, including general GI endoscopy and the Yale Liver Clinic. His primary clinical and research interests are focused on acute and chronic liver diseases, with emphasis on: 1) Viral hepatitis B and C, and 2) Fatty liver disorders, including non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). His current research focuses on the role of medical and surgical weight loss in the management of NAFLD, including a prospective study evaluating the effect of Roux-en-Y gastric bypass (RYGB) and laparoscopic adjustable gastric banding (LAGB) mediated alterations in lipid metabolism and foregut hormones on improvements in hepatic insulin resistance, liver histology, manifestations of the metabolic syndrome, and health-related quality of life (HRQoL) in morbidly obese patients with NAFLD.

Contact

Campus Address
Department of Internal Medicine
333 Cedar Street (LMP 1080)
New Haven, CT 06520

E-mail
joseph.lim@yale.edu

Office
Phone (203) 737-6063

Appointments
Phone (203) 785-4138